Thank you, Dr. Nemer.
I do think that indicates the problem with independence of your office and a lack of independence in the very attitude that is being expressed.
I want to go to Professor Kobinger, who was part of the vaccine task force and had concerns about the transparency surrounding that task force.
It seems to me there are two potential problems when a task force isn't transparent. One is the very narrow and direct conflict of interest of those who were involved with it. The second is the attitudinal conflict. In a group like the task force that had many people involved in the pharmaceutical industry, there's a danger that people weren't thinking about solutions other than those they were already involved in.
I'd like to hear Professor Kobinger on that point.